Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

LifeTime

Financiado

Revolutionizing Healthcare by Tracking and Understanding Human Cells during Dise...

Revolutionizing Healthcare by Tracking and Understanding Human Cells during Disease "Understanding how genomes function within cells, and how cells form tissues and dynamically remodel their activities when tissues progress towards disease is among the grand science and technology challenges of our era. The early... ver más

30/06/2020

MDC

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 21 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-06-30

FETFLAG-01-2018: Preparatory Actions for new FET Fla...

I+D

Cerrada hace 6 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

21 Participantes

MDC

621.25K€ | Lider

GRUPO EMPRESARIAL MUELA SL E...

CNRS

15.00K€ | Participante

FUNDACIO PRIVADA CENTRE DE R...

15.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RTI2018-101481-B-I00 DESARROLLO DE UNA PLATAFORMA DE MEDICINA DE PRECISION PARA E... 92K€ Cerrado

NIMSB NOVA Institute for Medical Systems Biology 15M€ Cerrado

AI4SYN Artificial intelligence for synthetic functional genomics of... 1M€ Cerrado

SCREEN4CARE Shortening the path to rare disease diagnosis by using newbo... 26M€ Cerrado

PTA2015-11737-I Nuevas tecnologías de secuenciación masiva y caracterización... 39K€ Cerrado

MultiCloneSeq Single-Clone Multi-omics Sequencing for Cancer Diagnosis 150K€ Cerrado

Duración del proyecto: 16 meses Fecha Inicio: 2019-02-11
Fecha Fin: 2020-06-30

Líder del proyecto

MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto "Understanding how genomes function within cells, and how cells form tissues and dynamically remodel their activities when tissues progress towards disease is among the grand science and technology challenges of our era. The early detection and interception of chronic and progressive diseases would alleviate enormous suffering and a heavy, growing burden on our economy and ageing society. LifeTime aims to revolutionize healthcare by developing and integrating several emerging, disruptive technologies (single-cell multi-omics, advanced imaging, machine learning/artificial intelligence (AI), organoids, and CRISPR-Cas). LifeTime technologies will track and decipher the activity of our genomes (our ""book of life"") in individual cells as they progress through time (ageing or disease)-""LifeTime"". LifeTime's unifying goal is to quantify, model, and predict cell trajectories in tissues and whole organisms. Its long-term vision is that LifeTime technologies will inform the physician about the molecular history of a patient's tissues, their future, and the consequences of perturbations or medical treatments, leading to early diagnosis and effective interception of disease. LifeTime scientists are world-leaders in the required technologies and are committed to establishing an open and dynamic network. LifeTime's focus on developing, integrating and applying several disruptive technologies will induce long-lasting structural changes in European life sciences and healthcare and establish leadership in AI applications for medicine. Together with many industrial partners, we will develop technologies to redefine diagnosis and pathology, and set new standards for mechanism-based drug discovery and disease management for the 21st century. Such advances and their ensuing medical transformation will significantly impact the health of European citizens and stimulate the economy with tremendous benefit for society as a whole."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores